[How can cardiac accidents, caused by therapy with beta blockers, be prevented?].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D000787:Angina Pectoris / Q000139:chemically induced* / Q000188:drug therapy / Q000517:prevention & control; D000788:Angina Pectoris, Variant / Q000517:prevention & control; D004071:Digitalis Glycosides / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000517:prevention & control; D009566:Nitrates / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D009566:Nitrates; D005934:Glucagon
Wie lassen sich kardiale Zwischenfälle bei Therapie mit Betablockern verhindern?